What is the Fiscal Year for Nektar Therapeutics?
Date: November 13, 2026
Nektar Therapeutics's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
San Francisco, California
Industry
Biotechnology
Stock Symbol
NKTR
Website
http://www.nektar.comDescription
Since its inception, Nektar has led with scientific ingenuity, unwavering resilience and a bold commitment to improving patients’ lives. We have built expertise spanning foundational scientific research, cutting-edge therapeutic discovery, clinical development, strategic partnerships and commercialization – all in pursuit of opportunities to improve outcomes for people with immune-mediated disease. Through the years, we have developed a proven track record of translating groundbreaking research into innovative therapies in partnership with leading pharmaceutical companies. We remain focused on advancing scientific discoveries into safer, more effective treatments for people living with autoimmune diseases and inflammatory conditions.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Nektar Therapeutics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.